Prosetta

Prosetta is an antiviral drug development company based in San Francisco, California. It was founded by UCSF researchers including Vishwanath Lingappa and Jaisri Lingappa. The company is working on small-molecule drugs (compounds that can be taken orally) to disrupt the capsids (protein coats) that viruses form for protection of their genes.^[1] The company's work includes research on antivirals to combat hepatitis C.^[2]

References[edit]

↑ Zimmer, Carl (20 March 2012). "Antiviral Drugs Could Blast the Common Cold—Should We Use Them?" – via www.wired.com.
↑ "Prosetta, antiviral-drug developer, raises $2M". 18 May 2007.

External links[edit]

Official website

This United States corporation or company article is a stub. You can help EverybodyWiki by expanding it.

This article "Prosetta" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Prosetta. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

📰 Article(s) of the same category(ies)[edit]

[1] Zimmer, Carl (20 March 2012). "Antiviral Drugs Could Blast the Common Cold—Should We Use Them?" – via www.wired.com.

[2] "Prosetta, antiviral-drug developer, raises $2M". 18 May 2007.

[1]

[2]